408
Participants
Start Date
October 24, 2011
Primary Completion Date
March 27, 2013
Study Completion Date
March 27, 2013
Meloxicam
7.5mg x2 once a day for 12 weeks
Placebo
Study subjects will be randomized to two treatment groups: one with Meloxicam 7.5 mgx2 once a day and another one with placebo. The duration of the interventional treatment is 12 weeks.
China-Japan Friendship Hospital/Rheumatology Department, Beijing
Peking Union Medical College Hospital, Beijing
Li Zhanguo, Beijing
Rheumatology and Immunology Department, Xuanwu Hospital Capital Medical University, Beijing
Peking Union Medical College Hospital, Orthopaedics, Beijing
Rheumatology Department, The first Affiliated Hospital of Harbin Medical University, Harbin
Renji Hospital Shanghai Jiao Tong University School of Medicine, Shanghai
Rheumatology and Immunology Department, Shanghai Changzheng Hospital, Shanghai
Zhongshan Hospital Fudan University, Rheumatology Department, Shanghai
Jiangsu Province Hospital, Nanjing
Anhui Province Hospital, Hefei
QiLu Hospital of Shandong University, Jinan
Liaocheng People's Hospital/Orthopaedics, Liaocheng
Department of Immunology and Rheumatology, Qingdao Municipal Hospital, Qingdao
Department of Immunology and Rheumatology,Qingdao Municipal Hospital, Qingdao
Department of Infectious Diseases & Immunology, Tianjin Medical University General Hospital, Tianjin
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
The Third Affiliated Hospital Of Sun Yat-sen University, Guangzhou
The First Affiliated Hospital of Shantou Medical Collage, Shantou
Department of Orthopedics, West China Hospital of Sichuan University, Chengdu
Department of Rheumatology and Immunology,West China Hospital of Sichuan University, Chengdu
Department of Rheumatology and Immunology, Sichuan Provincial People's Hospital, Chengdu
Sichuan Provincial People's Hospital, Rheumatology, Chengdu
Xijing Hospital, The Fourth Military Medical University, Xi’an
Rheumatology Department, The First Hospital of China Medical University, Shenyang
Lead Sponsor
Pfizer
INDUSTRY